• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 2
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 7
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Synthesis and Chracterization of Metal Complexes with N2S2 Coordination

Yang, Shin-Ying 30 August 2011 (has links)
In this study, we used different ways to synthetize four-coordinate zinc(II) and nickel(II) complexes with optically active Schiff base offering N2S2 coordination, i.e. N,N'-Bis(2-thiobenzylidene)-l,2-(R,R)cycholhexyl- enediaminatozinc(II) (1) and N,N'-Bis(2-thiobenzylidene)-l,2-(R,R)cychol- hexylenediaminatonickel(II) (2). We obtained the crystal structure of 2 and the pyridine adduct of 1, N,N'-Bis(2-thiobenzylidene)-l,2-(R,R)cycholhexylenediaminopyridylzinc(II) (1¡DPy). Coordination geometry around Zn atom in 1¡DPy is a distorted trigonal bipyramid. These structures were compared with the N2O2 stuctural analogues reported in the literature. We hope these chiral complexes can make contribution to the enzyme model studies in the future.
2

Nickel Complexes Incorporating the Triazine-Based PN3P Pincer and the Nonsymmetrical PONNP Pincer Ligands

Huang, Mei-Hui 03 1900 (has links)
As an extension of the previous work on the post-modification strategy of pyridine-based PN3P group 10 metal complexes, the triazine-based PN3P pincer ligands incorporating nickel complexes, Me-Et-PN3PNiCl, and Me-Et-PN3PNiI, were synthesized and characterized. The solid state structures suggest that the N-donor atom of triazine-based PN3P ligands have more electron donating than the pyridine-based PNP pincer ligands. A new non-symmetric PONNP pincer ligand system was developed to: (1) give more parameters for electronic and steric properties (2) to block the influence of acidic proton. However, the unstable metal-hydride complexes indicate the degradable O–P bond or N–P bond of the PONNP ligand. Treating the three ligands, including tert-butyl, phenyl, and cyclopentyl substituents with NiCl2(DME) individually all resulted in the production of [(PtBuONNPtBu)NiCl]+Cl-. It suggests that both O‒P and N‒P can cleave and rearrange during the complexation. The solvent effect and time tracing experiments demonstrated that the O‒P and N‒P bond rearrangement occurs after forming the nickel complex. The finding of [(ONNPtBu)NiCl]22+(Cl-)2 indicates the weakness of the O‒P bond, suggesting the degradation of an oxygen-phosphorus bond may be the initial step of substituents rearrangement. To ensure the ligand-centered reactivity of (PtBuONNPtBu)*NiCl, a nickel-silver bimetallic complex, [(PtBuONNPtBu)*NiCl]2[AgOTf]2, was produced. In contrast to pyridine-based PN3P*NiH, there are two active sites of [(PtBuONNPtBu)*NiCl]2[AgOTf]2, the N atoms on the imine arm and pyrimidine ring. The solid-structure of the acid-base adduct compound, {[(PtBuONNPtBu)*NiCl][B(C6F5)3], demonstrates that the nitrogen atom on the pyrimidine ring is a better active site than the imine arm because of the steric effect. The molecular structures of [(PtBuONNPtBu)*NiCl]2[AgOTf]2 and {[(PtBuONNPtBu)*NiCl][B(C6F5)3] exhibit that the pyrimidine ring of [(PtBuONNPtBu)*NiCl]2[AgOTf]2 tends to be an aromatic zwitterionic form. The ligand backbone of {[(PtBuONNPtBu)*NiCl][B(C6F5)3] favors the dearomatized form.
3

Conducteurs moléculaires neutres : complexes bis (dithiolène) d'or et de nickel / Neutral molecular conductors : gold and nickel bis(dithiolene) complexes

Filatre-Furcate, Agathe 29 September 2016 (has links)
Au cours de ce travail, nous nous sommes particulièrement intéressés à une classe de molécules électroactives précurseurs de matériaux moléculaires conducteurs à composant unique, les complexes bis(1,2-dithiolène) d'or et de nickel neutres. Nous avons tout d'abord développé une série originale de complexes radicalaires d'or [Au(R-thiazYdt)2] à partir de ligands dithiolène, riches en électron, les N-alkyl-1,3-thiazoline-2-chalcogénone-4,5-dithiolate (R-thiazYdt)2 avec Y = O, S, Se et R = Pr, iPr, cycloPr, NMe2. Le substituant R de l'hétérocycle joue un rôle majeur sur les propriétés des matériaux, résultant des interactions électroniques intermoléculaires entre ces complexes paramagnétiques. Les complexes de nickel diamagnétiques, [Ni(R-thiazSdt)2], des mêmes ligands dithiolène, présentent quant à eux une organisation à l'état solide très différente, conséquence de leur caractère à "couche fermée". Enfin, la réactivité originale des dérivés avec R = tBu conduit à des ligands dithiolène portés par un cycle aromatique 2-alkylthio-thiazole (RS-tzdt). Leurs complexes d'or neutres [Au(RS-tzdt)2] forment des empilements fortement dimérisés et semi-conducteurs. / During this work, we particularly focused on one type of electroactive molecules, precursors of single component molecular conductors, the neutral gold and nickel bis(1,2-dithiolene) complexes. First we developed a series of radical gold complexes [Au(R-thiazYdt)2] derived from electron rich dithiolene ligands, the N-alkyl-1,3-thiazoline-2-chalcogenone-4,5-dithiolate (R-thiazYdt)2 with Y = O, S, Se and R = Pr, iPr, cycloPr, NMe2. The R substituent plays an important role on the properties of these materials resulting from the intermolecular electronic interactions between these paramagnetic complexes. Besides, diamagnetic nickel complexes, [Ni(R-thiazSdt)2], with the same dithiolene ligands exhibit a different organization in the solid state, a consequence of their closed shell nature. Finally, the original reactivity of the derivatives with R = tBu leads to dithiolene ligands with an aromatic 2-alkylthio-1,3-thiazole ring (RS-tzdt). Their neutral gold complexes [Au(RS-tzdt)2] form semi-conducting strongly dimerized stacks.
4

Estudo de uma nova rota sintética para o fármaco (R)-baclofen / Investigation of a New Synthetic Route to (R)-Baclofen

Barazzone, Giovana Cappio 06 December 2007 (has links)
O objetivo principal deste trabalho foi a investigação da viabilidade de uma nova rota sintética para a obtenção do fármaco Baclofen em sua forma enantiopura. A etapa principal da rota sintética por nós proposta consiste na síntese de uma aziridina de estereoquímica cis, utilizando uma nova metodologia, desenvolvida em nosso laboratório pelo emprego da catálise de transferência de fase (CTF). Para a obtenção da aziridina apropriada, tornou-se necessário preparar de maneira estereosseletiva, a (2S, 3R)-(4-clorofenil)-serina. Este precursor seria adequado, uma vez que, em estudos preliminares, verificamos que o fechamento do aziridínico ocorre sem racemização dos estereocentros presentes na molécula. Inicialmente, tentamos obter o β-hidróxi-α-aminoácido desejado pela reação de adição aldólica de uma imina do éster terc-butílico da glicina com o 4-clorobenzaldeído, em condições de catálise de transferência de fase assimétrica. Tais reações não apresentaram estereosseletividade. Porém, apesar de gerarem dois produtos diastereoméricos racêmicos, estes são de interesse, uma vez que um deles é uma oxazolidina cis inédita. Para a obtenção da (2S, 3R)-(4-clorofenil)-serina, optamos pelo emprego de uma metodologia alternativa, que consistiu em efetuar a reação aldólica do p-clorobenzaldeído com a glicina, sob a forma de um complexo de quiral de níquel (II). Uma vez obtido o ß-hidróxi-α-aminoácido, efetuamos a reação de aziridinização, seguida da abertura do anel heterocíclico com malonato de dietila, o que resultou na obtenção da (2S,3R) 4-carboetóxi-3-(4-clorofenil)-1-tosil-piroglutamato de metila, que consiste em uma mistura de diastereoisômeros, mas de estereoquímica definida nos carbonos 2 e 3. A hidrólise dos grupos ésteres deste composto, seguida de mono-descarboxilação do diácido resultante, conduziu ao ácido 3-(4-clorofenil)-1-tosil-piroglutâmico opticamente ativo, em 17% a partir da aziridina. As etapas finais de transformação de transformação deste intermediário no fármaco Baclofen não foram efetuadas. No entanto, consistem em reações bem descritas na literatura e freqüentemente utilizadas em outras rotas visando a síntese do mesmo fármaco. / In this work, the feasibility of a new synthetic route to Baclofen was investigated. The starting material, a cis-aziridine, was prepared by ring closure of (2S,3R)-(4-clorophenyl)- serine, under phase transfer conditions (PTC). As for the preparation of the required ß- hydroxy-α-aminoacid, two alternative synthetic strategies were investigated. (i) the PTC aldol addition of 4-chlorobenzaldehyde to the benzophenone imine of the tert-butyl ester of glycine, using chiral catalysts, or (ii) the aldol addition of the same aldehyde to a chiral nickel (II) complex of glycine. The first mentioned reaction failed to yield enantiomerically pure aldol adducts, although a cis oxazolidina, not yet described in the literature, could be isolated and fully characterized. Using a newly prepared nickel complex, bearing (R)-proline as ligand, (2S,3R)-(4-chlorophenyl)-serine could be prepared and subsequentely transformed into the corresponding aziridina. Ring opening of heterocycle, using diethylmalonate as nucleophile, afforded N-tosyl-4-carbethoxy-3-(4-chlorophenyl)-methyl pyroglutamate as a mixture of diastereomers but with defined stereochemistry at C-2 and C-3. Hydrolysis and mono- decarboxalation led to the corresponding N-tosyl-3-(4-chlorophenyl)-pyroglutamic acid, exhibiting optical activity. This valuable intermediate could be prepared in 17% from the starting aziridina and can be further transformed into the γ-aminoacid Baclofen using fully investigated and well described procedures.
5

Estudo de uma nova rota sintética para o fármaco (R)-baclofen / Investigation of a New Synthetic Route to (R)-Baclofen

Giovana Cappio Barazzone 06 December 2007 (has links)
O objetivo principal deste trabalho foi a investigação da viabilidade de uma nova rota sintética para a obtenção do fármaco Baclofen em sua forma enantiopura. A etapa principal da rota sintética por nós proposta consiste na síntese de uma aziridina de estereoquímica cis, utilizando uma nova metodologia, desenvolvida em nosso laboratório pelo emprego da catálise de transferência de fase (CTF). Para a obtenção da aziridina apropriada, tornou-se necessário preparar de maneira estereosseletiva, a (2S, 3R)-(4-clorofenil)-serina. Este precursor seria adequado, uma vez que, em estudos preliminares, verificamos que o fechamento do aziridínico ocorre sem racemização dos estereocentros presentes na molécula. Inicialmente, tentamos obter o β-hidróxi-α-aminoácido desejado pela reação de adição aldólica de uma imina do éster terc-butílico da glicina com o 4-clorobenzaldeído, em condições de catálise de transferência de fase assimétrica. Tais reações não apresentaram estereosseletividade. Porém, apesar de gerarem dois produtos diastereoméricos racêmicos, estes são de interesse, uma vez que um deles é uma oxazolidina cis inédita. Para a obtenção da (2S, 3R)-(4-clorofenil)-serina, optamos pelo emprego de uma metodologia alternativa, que consistiu em efetuar a reação aldólica do p-clorobenzaldeído com a glicina, sob a forma de um complexo de quiral de níquel (II). Uma vez obtido o ß-hidróxi-α-aminoácido, efetuamos a reação de aziridinização, seguida da abertura do anel heterocíclico com malonato de dietila, o que resultou na obtenção da (2S,3R) 4-carboetóxi-3-(4-clorofenil)-1-tosil-piroglutamato de metila, que consiste em uma mistura de diastereoisômeros, mas de estereoquímica definida nos carbonos 2 e 3. A hidrólise dos grupos ésteres deste composto, seguida de mono-descarboxilação do diácido resultante, conduziu ao ácido 3-(4-clorofenil)-1-tosil-piroglutâmico opticamente ativo, em 17% a partir da aziridina. As etapas finais de transformação de transformação deste intermediário no fármaco Baclofen não foram efetuadas. No entanto, consistem em reações bem descritas na literatura e freqüentemente utilizadas em outras rotas visando a síntese do mesmo fármaco. / In this work, the feasibility of a new synthetic route to Baclofen was investigated. The starting material, a cis-aziridine, was prepared by ring closure of (2S,3R)-(4-clorophenyl)- serine, under phase transfer conditions (PTC). As for the preparation of the required ß- hydroxy-α-aminoacid, two alternative synthetic strategies were investigated. (i) the PTC aldol addition of 4-chlorobenzaldehyde to the benzophenone imine of the tert-butyl ester of glycine, using chiral catalysts, or (ii) the aldol addition of the same aldehyde to a chiral nickel (II) complex of glycine. The first mentioned reaction failed to yield enantiomerically pure aldol adducts, although a cis oxazolidina, not yet described in the literature, could be isolated and fully characterized. Using a newly prepared nickel complex, bearing (R)-proline as ligand, (2S,3R)-(4-chlorophenyl)-serine could be prepared and subsequentely transformed into the corresponding aziridina. Ring opening of heterocycle, using diethylmalonate as nucleophile, afforded N-tosyl-4-carbethoxy-3-(4-chlorophenyl)-methyl pyroglutamate as a mixture of diastereomers but with defined stereochemistry at C-2 and C-3. Hydrolysis and mono- decarboxalation led to the corresponding N-tosyl-3-(4-chlorophenyl)-pyroglutamic acid, exhibiting optical activity. This valuable intermediate could be prepared in 17% from the starting aziridina and can be further transformed into the γ-aminoacid Baclofen using fully investigated and well described procedures.
6

Bioinspired Redox Active Pseudotetrahedral Ni(II) Thiolate and Phenolate Complexes: Synthesis, Characterization, Alkylation Kinetics and Molecular Oxygen Activation

Deb, Tapash K. January 2013 (has links)
No description available.
7

Pyrazolat-liganden mit zwei facial tridentaten Koordinationstaschen - Metallkomplexe und erste Reaktivitätsuntersuchungen / Pyrazole based ligands with two facial tridentate coordination pockets - metal complexes and first investigations of reactivity

Müller, Holger 01 November 2007 (has links)
No description available.

Page generated in 0.0617 seconds